DataMeds outlines peptide compounding plans after FDA policy proposal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: DVLT) | Delayed: 0.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.13 | 52 Week High | $ | |||
| Open | $0.13 | 52 Week Low | $ | |||
| Day High | $0.14 | P/E | N/A | |||
| Day Low | $0.13 | EPS | $ | |||
| Volume | 10,821,320 | |||||
| Medistem, Inc. (NASDAQ: MEDS) | Delayed: 2.24 -0.06 (2.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.30 | 52 Week High | $2.80 | |||
| Open | $2.33 | 52 Week Low | $0.08 | |||
| Day High | $2.37 | P/E | N/A | |||
| Day Low | $2.23 | EPS | $0.00 | |||
| Volume | 278,421 | |||||
